WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014178383) DIAGNOSIS OF FEBRILE NEUTROPENIA BY MEASURING PRESEPSIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/178383    International Application No.:    PCT/JP2014/061897
Publication Date: 06.11.2014 International Filing Date: 28.04.2014
IPC:
G01N 33/68 (2006.01), C07K 16/30 (2006.01), C12Q 1/04 (2006.01), G01N 33/53 (2006.01), G01N 33/80 (2006.01)
Applicants: MOCHIDA PHARMACEUTICAL CO., LTD. [JP/JP]; 7, Yotsuya 1-chome, Shinjuku-ku, Tokyo 1608515 (JP)
Inventors: NAKAMAE Hirohisa; (JP).
KOH Hideo; (JP)
Agent: KOBAYASHI, Hiroshi; ABE, IKUBO & KATAYAMA, Fukuoka Bldg. 9th Fl., 8-7, Yaesu 2-chome, Chuo-ku Tokyo 1040028 (JP)
Priority Data:
2013-095554 30.04.2013 JP
Title (EN) DIAGNOSIS OF FEBRILE NEUTROPENIA BY MEASURING PRESEPSIN
(FR) DIAGNOSTIC DE LA NEUTROPÉNIE FÉBRILE PAR MESURE DE LA PRÉSEPSINE
(JA) プレセプシン測定による発熱性好中球減少症の診断
Abstract: front page image
(EN)A method for detecting febrile neutropenia in a cancer patient by using as an index the sCD14-ST concentration in a blood specimen that is obtained from the cancer patient, and a method for selecting a febrile neutropenia patient to whom an antibiotic is to be administered by using as an index the aforesaid sCD14-ST concentration.
(FR)L'invention concerne une méthode de détection de la neutropénie fébrile chez un patient cancéreux, dans laquelle la concentration de sCD14-ST dans un échantillon sanguin prélevé sur le patient cancéreux est utilisée en tant qu'indice ; ainsi qu'une méthode qui permet de sélectionner un patient atteint de neutropénie fébrile auquel un antibiotique doit être administré, dans laquelle ladite concentration de sCD14-ST est utilisée en tant qu'indice.
(JA) がん患者由来の血液検体中のsCD14-ST濃度を指標に用いる、がん患者における発熱性好中球減少症の検出方法、および抗生剤を投与する対象となる発熱性好中球減少症患者の選択方法。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)